{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:08:20Z","timestamp":1787875700288,"version":"build-2784847793"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Primary cutaneous acral CD8+ T-cell lymphoproliferative disorder (TLPD) is a rare and indolent lymphoma entity. Although TLPD was first identified many years ago, the molecular pathogenesis is still not fully understood.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>In order to better understand the molecular pathogenesis of cutaneous acral CD8+ TLPD and to identify further discriminatory markers to differentiate this lymphoma subtype from other CD8+ cutaneous lymphomas, we analysed five cases of cutaneous acral CD8+ TLPD for putative molecular alterations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Somatic alterations were assessed using whole-exome and targeted sequencing of paraffin-embedded tissue. Results were evaluated using immunohistochemical staining of respective relevant proteins. CD8+ cutaneous T-cell lymphomas (n = 12) served as control for KIR3DL1 staining.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Copy number variation analysis revealed a homozygous deletion of the KIR3DL1 gene in two of the analysed cases. This resulted in loss of KIR3DL1 protein expression, which was observed in all cases of cutaneous acral CD8+ TLPD. In contrast, KIR3DL1 expression was more variable in other CD8+ cutaneous T-cell lymphomas with 50% of analysed cases (n = 12) found to be positive. In addition, one further case of acral CD8+ TLPD harboured a loss-of-function mutation in the PIK3R1 gene, presumably activating the phosphoinositide 3-kinase-AKT pathway.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Alterations of the KIR3DL1 gene may be of pathogenetic relevance for acral CD8+ TLPD. Loss of KIR3DL1 protein expression may support the diagnosis of this indolent lymphoma entity; however, this is not a subtype-specific discriminative feature.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljae256","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T20:03:04Z","timestamp":1719432184000},"page":"816-822","source":"Crossref","is-referenced-by-count":4,"title":["Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6293-2554","authenticated-orcid":false,"given":"Marion","family":"Wobser","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology and Skin Cancer Center, University Hospital W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Appenzeller","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center Mainfranken, University Hospital of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Roth","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center Mainfranken, University Hospital of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]},{"name":"Institute of Pathology, University of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Siedel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology and Skin Cancer Center, University Hospital W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Goebeler","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology and Skin Cancer Center, University Hospital W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Geissinger","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]},{"name":"Pathology Practice , Ingolstadt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center Mainfranken, University Hospital of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]},{"name":"Institute of Pathology, University of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Maurus","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center Mainfranken, University Hospital of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]},{"name":"Institute of Pathology, University of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"2024102112264101400_ljae256-B1","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjd.20973","article-title":"Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T-cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop","volume":"186","author":"Kempf","year":"2022","journal-title":"Br J Dermatol"},{"key":"2024102112264101400_ljae256-B2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"2024102112264101400_ljae256-B3","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jdv.19987","article-title":"Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group","volume":"38","author":"Kempf","year":"2024","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"2024102112264101400_ljae256-B4","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/PAS.0b013e318068b527","article-title":"Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?","volume":"31","author":"Petrella","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2024102112264101400_ljae256-B5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/bjh.15572","article-title":"Primary cutaneous acral CD8+ T-cell lymphomas relapse more frequently in younger patients","volume":"185","author":"Maubec","year":"2019","journal-title":"Br J Haematol"},{"key":"2024102112264101400_ljae256-B6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/DAD.0b013e3182a74c7a","article-title":"Multicenter case series of indolent small\/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face","volume":"36","author":"Li","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"2024102112264101400_ljae256-B7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40487-016-0026-y","article-title":"Cutaneous CD8+ cytotoxic t-cell lymphoma infiltrates: clinicopathological correlation and outcome of 35 cases","volume":"4","author":"Wobser","year":"2016","journal-title":"Oncol Ther"},{"key":"2024102112264101400_ljae256-B8","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/bjd.13628","article-title":"CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas","volume":"172","author":"Wobser","year":"2015","journal-title":"Br J Dermatol"},{"key":"2024102112264101400_ljae256-B9","doi-asserted-by":"crossref","first-page":"1231601","DOI":"10.3389\/fonc.2023.1231601","article-title":"Targeted panel sequencing in the routine diagnosis of mature T- and NK-cell lymphomas: report of 128 cases from two German reference centers","volume":"13","author":"B\u00f6ck","year":"2023","journal-title":"Front Oncol"},{"key":"2024102112264101400_ljae256-B10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"2024102112264101400_ljae256-B11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1615\/CritRevImmunol.2013007409","article-title":"The yin-yang of KIR3DL1\/S1: molecular mechanisms and cellular function","volume":"33","author":"O\u2019Connor","year":"2013","journal-title":"Crit Rev Immunol"},{"key":"2024102112264101400_ljae256-B12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.coi.2012.01.001","article-title":"NK cell MHC class I specific receptors (KIR): from biology to clinical intervention","volume":"24","author":"Thielens","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"2024102112264101400_ljae256-B13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2567.2010.03398.x","article-title":"Structure\/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations","volume":"132","author":"Campbell","year":"2011","journal-title":"Immunology"},{"key":"2024102112264101400_ljae256-B14","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.4049\/jimmunol.0901734","article-title":"Dimorphic motifs in D0 and D1 + D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402","volume":"183","author":"Sharma","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"2024102112264101400_ljae256-B15","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0002-9440(10)63014-3","article-title":"Restricted killer cell immunoglobulin-like receptor repertoire without T-cell receptor gamma rearrangement supports a true natural killer-cell lineage in a subset of sinonasal lymphomas","volume":"159","author":"Lin","year":"2001","journal-title":"Am J Pathol"},{"key":"2024102112264101400_ljae256-B16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0145-2126(03)00024-9","article-title":"Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma","volume":"27","author":"Matsuo","year":"2003","journal-title":"Leuk Res"},{"key":"2024102112264101400_ljae256-B17","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ajpath.2016.02.011","article-title":"Diagnostic and biological significance of KIR expression profile determined by RNA-Seq in natural killer\/t-cell lymphoma","volume":"186","author":"K\u00fc\u00e7\u00fck","year":"2016","journal-title":"Am J Pathol"},{"key":"2024102112264101400_ljae256-B18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20021127","article-title":"DNA methylation maintains allele-specific KIR gene expression in human natural killer cells","volume":"197","author":"Chan","year":"2003","journal-title":"J Exp Med"},{"key":"2024102112264101400_ljae256-B19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-0625.2012.01489.x","article-title":"CD158k\/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides","volume":"21","author":"Ortonne","year":"2012","journal-title":"Exp Dermatol"},{"key":"2024102112264101400_ljae256-B20","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/bjd.18481","article-title":"Revisiting the initial diagnosis and blood staging of mycosis fungoides and S\u00e9zary syndrome with the KIR3DL2 marker","volume":"182","author":"Roelens","year":"2020","journal-title":"Br J Dermatol"},{"key":"2024102112264101400_ljae256-B21","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1470-2045(19)30320-1","article-title":"IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial","volume":"20","author":"Bagot","year":"2019","journal-title":"Lancet Oncol"},{"key":"2024102112264101400_ljae256-B22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.2823","article-title":"Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK\/T cell lymphoma revealed by gene expression profiling","volume":"223","author":"Ng","year":"2011","journal-title":"J Pathol"},{"key":"2024102112264101400_ljae256-B23","first-page":"1158","article-title":"Correspondence article regarding CD68 as a marker of CD8+ lymphoid proliferation suggested by Wobser et al","volume-title":"Br J Dermatol","author":"Lecamwasam","year":"2016"},{"key":"2024102112264101400_ljae256-B24","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.3390\/cancers13215512","article-title":"Targeted deep sequencing of mycosis fungoides reveals intracellular signaling pathways associated with aggressiveness and large cell transformation","volume":"13","author":"Wobser","year":"2021","journal-title":"Cancers"},{"key":"2024102112264101400_ljae256-B25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00428-022-03421-5","article-title":"Recent advances in cutaneous lymphoma-implications for current and future classifications","volume":"482","author":"Goodlad","year":"2023","journal-title":"Virchows Arch"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljae256\/58869127\/ljae256.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/191\/5\/816\/59927282\/ljae256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/191\/5\/816\/59927282\/ljae256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T12:27:23Z","timestamp":1729513643000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/191\/5\/816\/7699817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6,27]]},"published-print":{"date-parts":[[2024,10,17]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljae256","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,6,27]]}}}